Indoor Harvest Corp (INQD)

[Mariijuana Invest]

Indoor Harvest Corp. (OTCQB: INQD) through its brand name Indoor Harvest®, is a technology company focused on enabling the production of biopharma grade cannabis for research and development of true pharma grade personalized medicines. The Company has a pending applicant under the Texas Compassionate Use Program and is planning to develop facilities in Arizona and Colorado. In August 2017, the Company completed a reverse triangular merger with Alamo CBD, exchanging 7,584,008 shares of Indoor Harvest's common stock, thus making Alamo CBD a wholly-owned subsidiary of the Company. Alamo CBD is a pending applicant to produce cannabis in Texas, placing 16th out of 43 applicants, under the Texas Compassionate Use Program. So far, three applicants have been awarded approvals to produce cannabis under the program. "We have our foot in the door with our pending application and have put into place some really great partnerships, both in science and technology. With the world's largest and most respected medical complex located in Houston, hosting both medical research and treatment facilities, the future of pharmaceutical development of cannabis in the state of Texas is quite promising," stated Dan Weadock, Indoor Harvest's Chief Executive Officer.

https://www.prnewswire.com/news-releases/recent-developments-in-the-medical-and-legal-cannabis-industry-684843461.html